Cargando…

Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center

BACKGROUND: The potential treatment effects of heat shock protein 90 (Hsp90) inhibitors in ovarian cancer (OC) are controversial. This research aims to investigate the relationship between the level of Hsp90 in peripheral blood and the prognosis of OC patients, as well as the clinicopathological ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Cancan, Li, KuoKuo, Pan, Xiaohua, Wei, Zhaolian, Xiao, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230804/ https://www.ncbi.nlm.nih.gov/pubmed/37259027 http://dx.doi.org/10.1186/s12885-023-10929-9

Ejemplares similares

Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases
por: Tukaj, Stefan, et al.
Publicado: (2022)

Potential role of heat shock protein 90 (Hsp90) in HIV uncoating
por: Joshi, Pheroze, et al.
Publicado: (2011)

The Adaptive Potential of the Middle Domain of Yeast Hsp90
por: Cote-Hammarlof, Pamela A, et al.
Publicado: (2020)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Hsp90 Inhibitors Prevent HSV-1 Replication by Directly Targeting UL42-Hsp90 Complex
por: Qin, Shurong, et al.
Publicado: (2022)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation
por: Jiao, Yisheng, et al.
Publicado: (2011)

Hsp-90 and the biology of nematodes
por: Him, Nik AIIN, et al.
Publicado: (2009)

Mechanisms of Hsp90 regulation
por: Prodromou, Chrisostomos
Publicado: (2016)

Regulatory Mechanisms of Hsp90
por: Prodromou, Chrisostomos
Publicado: (2017)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Role of HSP90 in Cancer
por: Birbo, Bereket, et al.
Publicado: (2021)

Organismal Roles of Hsp90
por: van Oosten-Hawle, Patricija
Publicado: (2023)

High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer
por: Zhang, Shuming, et al.
Publicado: (2019)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)

Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
por: Park, Hye-Kyung, et al.
Publicado: (2020)

Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy
por: Shetake, Neena G., et al.
Publicado: (2023)

The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases
por: Roberts, Richard J., et al.
Publicado: (2021)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Kijima, Toshiki, et al.
Publicado: (2018)

The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
por: Lackie, Rachel E., et al.
Publicado: (2017)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

Hsp40s Specify Functions of Hsp104 and Hsp90 Protein Chaperone Machines
por: Reidy, Michael, et al.
Publicado: (2014)

S-glutathionylation of Hsp90 enhances its degradation and correlates with favorable prognosis of breast cancer
por: Shih, Yu-Yin, et al.
Publicado: (2022)

Control of Canalization and Evolvability by Hsp90
por: Milton, Claire C., et al.
Publicado: (2006)

Targeting HSP90 for cancer therapy
por: Mahalingam, D, et al.
Publicado: (2009)

Hsp90 depletion goes wild
por: Siegal, Mark L, et al.
Publicado: (2012)

The ‘active life’ of Hsp90 complexes()
por: Prodromou, Chrisostomos
Publicado: (2012)

Hsp90, the Concertmaster: Tuning Transcription
por: Khurana, Nidhi, et al.
Publicado: (2015)

Hsp90 Promotes Kinase Evolution
por: Lachowiec, Jennifer, et al.
Publicado: (2015)

Targeting Hsp90 in urothelial carcinoma
por: Chehab, Mahmoud, et al.
Publicado: (2015)

Distinct Roles of Molecular Chaperones HSP90α and HSP90β in the Biogenesis of KCNQ4 Channels
por: Gao, Yanhong, et al.
Publicado: (2013)

A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)
por: Shahinas, Dea, et al.
Publicado: (2013)

C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
por: Fan, Yingjuan, et al.
Publicado: (2017)

Aberrant HSP90 Expression in Lymphocytes and HSP90 Response to Anti-PD-1 Therapy in Lymphoma Patients
por: Albakova, Zarema, et al.
Publicado: (2022)

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
por: Usmani, Saad Z, et al.
Publicado: (2010)

Plasma HSP90α and liver cancer: a potential biomarker?
por: Sourbier, Carole
Publicado: (2017)

Essential oil from Cymbopogon flexuosus as the potential inhibitor for HSP90
por: Gaonkar, Roopa, et al.
Publicado: (2018)

Therapeutic Potential of the Hsp90/Cdc37 Interaction in Neurodegenerative Diseases
por: Gracia, Liam, et al.
Publicado: (2019)

Development of machine learning models for the screening of potential HSP90 inhibitors
por: Khan, Mohd Imran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_860jig349cnd8tkbmivsejkkjr